380881-45-8

Basic information

• Product Name: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]propionic acid methyl ester
• Synonyms: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]propionic acid methyl ester
• CAS NO: 380881-45-8
• Molecular Weight: 420.462
• Mol File: 380881-45-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]propionic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]propionic acid methyl ester(380881-45-8)
• EPA Substance Registry System: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]propionic acid methyl ester(380881-45-8)

Safety Data

• Hazardous Substances Data: 380881-45-8(Hazardous Substances Data)

Upstream product

• 606932-78-9 3-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)acrylic acid methyl ester 
• 116518-98-0 E-3-(3,5-dimethoxy-phenyl)-2-(4-hydroxy-phenyl)-acrylic Acid 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 156-38-7 4-hydroxyphenylacetate 
• 459-57-4 4-fluorobenzaldehyde 
• 380881-43-6 3-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)propionic acid methyl ester 

Relevant articles and documents

Novel heterocyclic analogs of diphenylethylene compounds

Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. The compounds are disclosed as useful for a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.

Novel heterocyclic analogs of diphenylethylene compounds

Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of